-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeUSDISIN US28176E1082-
Edwards Lifesciences Corp.Börse NYSE New York Stock ExchangeISIN US28176E1082 WKN: 936853USDSymbol EW
-
EDWARDS LIFESCIENCES CORPBörse Börse BerlinEURSymbol EWL
-
EDWARDS LIFESCIENCES CORPBörse Börse StuttgartEURSymbol EWL
-
EDWARDS LIFESCIENCES CORPBörse Börse DüsseldorfEURSymbol EWL
-
EDWARDS LIFESCIENCES CORPBörse Börse MünchenEURSymbol EWL
-
EDWARDS LIFESCIENCES CORPBörse Quotrix System der Börse DüsseldorfEURSymbol EWL
-
EDWARDS LIFESCIENCES CORPBörse Börse FrankfurtEURSymbol EWL
-
EDWARDS LIFESCIENCES CORPBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol EWL
-
BRL
-
Symbol EWL
-
Symbol EWL
-
MXN
-
ISIN US28176E1082
WKN 936853
Symbol EW
Währung
USD
Börse
NYSE New York Stock Exchange
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 86,94 EUR +0,25%
Portrait der Edwards Lifesciences Aktie
Das Unternehmen Edwards Lifesciences aus USA ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Edwards Lifesciences ist in mehr als 72 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter Global X Longevity Thematic ETF gewichtet Edwards Lifesciences mit 3,48% im ETF.
Entdecke die 6 ETFs in denen Edwards Lifesciences am höchsten gewichtet ist Insgesamt in 72 ETFs enthalten
Dir gefallen die Informationen zu Edwards Lifesciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Edwards Lifesciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Edwards Lifesciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Edwards Lifesciences?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
27 News & Informationen zur Edwards Lifesciences Aktie
Amazon, Mastercard, Pinterest and More Friday Afternoon Analyst Upgrades and Downgrades – 24
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Friday, including Amazon.com, Edwards Lifesciences, Gilead Sciences, Mastercard and Pinterest.
Edwards Lifesciences Corporation (EW) Q2 2021 Earnings Call Transcript
EW earnings call for the period ending June 30, 2021.
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q2 2021 Results – Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE:EW) Q2 2021 Earnings Conference Call July 29, 2021 5:00 PM ET Company Participants Mark Wilterding – President, Investor Relations Mike Mussallem -…
Edwards Lifesciences (EW) Q2 Earnings and Revenues Surpass Estimates
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 16.36% and 7.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Edwards Lifesciences EPS beats by $0.09, beats on revenue (NYSE:EW)
Edwards Lifesciences (EW): Q2 Non-GAAP EPS of $0.64 beats by $0.09; GAAP EPS of $0.78 beats by $0.28.Revenue of $1.38B (+49.2% Y/Y) beats by $100M.TAVR sales exceeded expectations and…
Stocks That Hit 52-Week Highs On Tuesday
This morning 85 companies set new 52-week highs.
Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet …
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was s…
Study Data Presented At TVT On The Economics Of Minimalist TAVR, PARTNER 3 Bicuspid TAVR
IRVINE, Calif., July 22, 2021 /PRNewswire/ — Edwards Lifesciences EW today announced that clinical and economic results from the 3M (multidisciplinary,
Study Data Presented at TVT on the Economics of Minimalist TAVR, PARTNER 3 Bicuspid TAVR
/PRNewswire/ — Edwards Lifesciences (NYSE: EW) today announced that clinical and economic results from the 3M (multidisciplinary, multimodality, but…
Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
IRVINE, Calif., July 22, 2021 /PRNewswire/ — Edwards Lifesciences EW plans to announce its operating results for the quarter ended June 30, 2021 after the
EDWARDS LIFESCIENCES : BYLAWS (Form 8-K)
EDWARDS LIFESCIENCES CORPORATION
BYLAWS
ARTICLE I
STOCKHOLDERS
SECTION 1…. | July 15, 2021
Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Q2 Release
Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Global Central Venous Catheters (CVCs) Market To Reach $1.5 Billion By 2026
SAN FRANCISCO, July 14, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today
Global Central Venous Catheters (CVCs) Market to Reach $1.5 Billion by 2026
SAN FRANCISCO, July 14, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…
3 Large-Cap Growth Stocks to Add to Your Portfolio This Summer By StockNews
3 Large-Cap Growth Stocks to Add to Your Portfolio This Summer
S&P Returns to Record Territory, but the NASDAQ Never Left
Stocks Analysis by Zacks Investment Research covering: Alphabet Inc Class A, BlackRock Inc, Edwards Lifesciences Corp, Echo Global Logistics Inc. Read Zacks Investment Research's latest article on Investing.com
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 146 stocks hit new 52-week highs.
Interesting Facts: The largest company by market cap to set a new 52-week high was …
Global Thrombectomy Devices Market to Surpass US$ 2,227.7 Million by 2027, Says Coherent Market Insights (CMI)
SEATTLE, June 28, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global thrombectomy devices market is estimated to be valued at US$…
Global Prosthetic Heart Valves Market to Reach $8.8 Billion by 2026
SAN FRANCISCO, June 25, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…
Global Prosthetic Heart Valves Market to Reach $8.8 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
10 Medical Device Stocks for 2021
In this article, we will take a look at some of the best medical device stocks for 2021. To skip our detailed analysis on the medical device industry,…
Stocks That Hit 52-Week Highs On Wednesday
This morning 122 companies reached new 52-week highs.
Interesting Facts: The largest company on a market cap basis to set a new 52-week high …
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET Tuesday, 59 stocks made new 52-week highs.
Intriguing Points: Microsoft (NASDAQ:MSFT) was the company with the largest market cap …
Hedge Funds Are Selling The Blackstone Group Inc. (BX)
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900…
Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out for
Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021
IRVINE, Calif., Jan. 13, 2021 /PRNewswire/ — Edwards Lifesciences EW plans to announce its operating results for the quarter ended December 31, 2020 after the
Health-care picks for portfolios
Vaccines, therapeutics provide growth opportunities